Cambridge Investment Research Advisors’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-81,011
Closed -$2.15M 3257
2023
Q1
$2.15M Buy
81,011
+16,051
+25% +$417K 0.01% 1084
2022
Q4
$1.63M Buy
+64,960
New +$1.64M 0.01% 1196

Other funds holding NVBT

Cambridge Investment Research Advisors's NVBT Position: Q2 2023 in Review

Cambridge Investment Research Advisors sold out of AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) in Q2 2023, closing a stake of 81,011 shares — an estimated $2.15M sold.

Cambridge Investment Research Advisors first reported a position in NVBT in Q4 2022 and held it in 2 quarters. The position peaked at $2.15M in Q1 2023. 8 funds tracked by Wall St. Rank hold NVBT as of Q2 2023.

  • Cambridge Investment Research Advisors reported no remaining AllianzIM U.S. Equity Buffer10 Nov ETF position as of Q2 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 81,011 AllianzIM U.S. Equity Buffer10 Nov ETF shares in Q2 2023, an estimated $2.15M.
  • Cambridge Investment Research Advisors first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q4 2022 and held it in 2 quarters.
  • Cambridge Investment Research Advisors's AllianzIM U.S. Equity Buffer10 Nov ETF position peaked at $2.15M in Q1 2023.
  • 8 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q2 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2023, filed 13 Jul 2023.